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Background and aims: Limited data exist on the association of the anatomical distribution of athero-
sclerotic lesions and the extent of atherosclerosis at defined arterial segments with life expectancy. We
recently presented a new classification of the extent of atherosclerosis in crural vessels and showed that
Crural Index (CIx) was associated with mid-term survival of symptomatic peripheral artery disease (PAD)
patients. This study evaluates the significance of the extent of crural atherosclerosis on long-term car-
diovascular mortality.
Methods: 887 consecutive patients with PAD, admitted for digital subtraction angiography (DSA) at
Turku University Hospital Department of Vascular Surgery (Turku, Finland) between January 1st, 2009
and July 30th, 2011, were retrospectively analysed. Each crural angiographic image was graded according
to CIx criteria. Aorto-iliac and femoro-popliteal arterial segments were similarly graded according to
modified TASC II criteria. CIx was used as the categorical variable for the extent of atherosclerosis in
crural vessels for survival analysis. Survival was also evaluated with respect to which arterial segment
was most severely affected. Causes of death were provided by the Cause of Death Registry of Statistics
Finland, updated on January 23rd, 2017.
Results: Altogether, 408 (46%) patients died during follow-up. The majority of deaths were due to car-
diovascular causes (n ¼ 246, 60%). Cardiovascular mortality was strongly associated with a high CIx (CIx
III (Hazard ratio (HR) 2.16, Confidence interval (CI) 95% 1.23e3.80, p ¼ 0.007)) and CIx IV (HR 3.513, 95%
CI 1.93e4.565, p < 0.001), as compared to CIx 0. In patients having the crural segment as the most
severely affected arterial segment, cardiovascular mortality was significantly increased (HR 2.321, 95% CI
1.45e3.73, p < 0.001), as was overall mortality (HR 2.177, 95% CI 1.53e3.10, p < 0.001).
Conclusions: High Crural Index and extensive crural vessel atherosclerosis are associated with long-term
cardiovascular mortality, and both may serve as useful indicators of survival among patients with
symptomatic PAD.
© 2017 Elsevier B.V. All rights reserved.putation free survival; CAD,





l, TE5 H€ameentie 11, 205211. Introduction
Cardiovascular disease is the most important causes of
morbidity and mortality in western countries. Patients with pe-
ripheral artery disease (PAD) appear to have the heaviest cardio-
vascular disease burden [1,2]. The prevalence of PAD has increased
within all age groups during the past 20 years [3].
With diagnosed large vessel PAD, life expectancy is shorter than
without diagnosis [4,5]. Furthermore, widespread atherosclerosis
of lower extremity arteries is associated with a higher mortality
compared to that of atherosclerosis localised to other vascular beds
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index (ABI) in atherosclerosis [1,2]. In addition to ABI, there are very
few clinical indicators to assess PAD outcome [6,7]. The relationship
of mortality with the extent of atherosclerosis at different vascular
segments of the lower limb has not been thoroughly investigated.
The need for new methods of risk assessment of PAD patients
has been emphasised [8]. The most widely used classification
describing the extent and severity of atherosclerotic lesions is
shown in the TASC [9] and TASC II [10,11] recommendations, which
aim to guide decision making in everyday practice. Additional
classifications of the severity and distribution of occlusive arterial
lesions in the lower extremity have been characterised [12,13], but
none of these have been shown to have predictive value regarding
patient outcome, and they are not widely used in clinical practice. A
runoff score of lower limb arteries has recently been characterised
and has been shown to associate with patient outcome and car-
diovascular events in revascularised patients [14]. These observa-
tions strongly suggest that the extent of atherosclerosis detected in
digital subtraction angiography (DSA) may be applied as an indi-
cator for patient outcome [15,16]. We have recently published a
simple tool to measure the extent of crural vessel atherosclerosis,
the Crural Index (CIx) [17,18]. High CIx and severe crural artery
disease are associated with increased mid-term overall mortality
and poor amputation-free survival, whereas lesions in the aorto-
iliac or femoro-popliteal regions, classified in a similar manner
adopted from the TASC II recommendations, do not comparably
affect outcome [17,18]. The present study aims to further elucidate
the significance of this finding regarding long-term overall and
cardiovascular mortality with a follow-up time of up to 7 years. The
TASC II classification for proximal lesions and CIx for crural lesions
were analysed, as well as outcome with respect to the most
severely diseased arterial segment.
2. Materials and methods
2.1. Patient cohort
887 consecutive patients, admitted at the Department of
Vascular Surgery at the Turku University Hospital, either for diag-
nostic DSA or endovascular treatment of PAD, from January 1st,
2009 to July 30th, 2011, were retrospectively analysed. All patients
were of Caucasian origin andwere included regardless of the earlier
treatment history. Both elective and urgent patients were recruited.
During recruitment, DSA was the gold standard for imaging of
atherosclerotic lesions in lower limb arteries at our department.
DSA images from the clinically more severely affected lower limb
were analysed. When both limbs met the criteria for critical limb
ischemia or were otherwise symptomatic, the limb with the lowest
average toe pressure was considered worse and entered into the
study. In case of repeated DSAs during the recruitment period, only
the first examination was analysed and taken into statistical ana-
lyses. The study was approved by the Ethical Committee of the
Hospital District of South-Western Finland.
Baseline characteristics were retrospectively collected from
Turku University Hospital electronic patient records, as described
in an earlier publication by Jalkanen et al. [18]. Only ICD-10 coded
diagnoses were registered. Risk factors were collected as follows;
coronary artery disease (CAD), cerebrovascular disease (CVD), hy-
pertension, active smoking, diabetes, sleep apnoea, chronic
obstructive pulmonary disease (COPD), end-stage renal disease
(ESRD), dyslipidaemia, ankle-brachial index (ABI), ankle pressure,
toe-brachial index (TBI), toe pressure, revascularisation modality
and medical treatment (anticoagulant, antithrombotic and statin).
The Rutherford classification [19] for clinical severity of PAD was
determined from patient files to assess the severity of ischemia. Thedate and official cause of death were provided by the Cause of
Death Registry of Statistics, Finland, on January 23rd, 2017. As the
Registry has a one-year delay registering official causes of death,
conclusive follow-up data for the cohort, including both the date
and official cause of death, was available for analysis until
31.12.2015, which was considered the cut-off point for follow-up.
2.2. DSA analysis
All DSA images were analysed by the corresponding author. The
crural vessels were first analysed separately and each vessel coded
as follows: no detectable occlusion or minor stenosis: 0; total oc-
clusion less than 5 cm: 1; total occlusion less than 10 cm: 2; total
occlusion less than 15 cm: 3; total occlusion more than 15 cm: 4.
The Crural Index was created by the sum of the codes for all three
individual crural vessels. If the sum was 0, the Crural Index was 0;
for sums 1e3, the Crural Indexwas I; for sums 4e6, the Crural Index
was II; for sums 7e9, the Crural Index was III; and for sums 10e12,
the Crural Index was IV.
Aorto-iliac and femoro-popliteal segments were classified as
described in TASC II [10,11]. Categorical variables for aorto-iliac and
femoro-popliteal segments (TASC II classification A-D) were coded
as follows; no disease: 0; TASC II A: 1; TASC II B: 2; TASC II C: 3;
TASC II D: 4.
To assess the prognostic effects of lesion distribution in different
arterial segments, each patient was assigned to a group of pre-
dominant disease localisation: 1) aorto-iliac, 2) femoro-popliteal
and 3) crural, based on which 0e4 rating gave the highest score.
If, for example, according to the TASC II classification, a patient had
proximal lesions of grade 0e2, but a Crural Index of III, the patient
was assigned to the crural group. If, however, the highest grade was
equal in two or even three localisations, the patient was assigned to
the group of the more proximal lesion with a similar score.
2.3. Statistical analyses
All statistical analyses were performed using the IBM SPSS
version 22 statistics program. Categorical variables were expressed
as frequency and percentage. For continuous variables, patient
characteristics were expressed as mean ± either standard deviation
(SD) or standard error (SE). Normal distribution was assessed with
Shapiro-Wilk tests. Survival analyses were assessed by Kaplan-
Meier curves and Log-rank statistics. A Cox regression analysis
was performed to assess the final predictive value of factors
affecting survival. Factors with p < 0.2 in Cox univariate analysis
were forced into a Cox proportional hazard model. Multivariate




Altogether, 408 (46%) patients died during follow-up. The dis-
tribution of causes of death in the study cohort and in the general
Finnish population aged >65 years is shown in Fig. 1. Mean age of
patients entering the study was 72.4 years, ranging from 40 to 98
years, and mean age at the end of follow-up was 76.3 years, ranging
from 43 to 98 years. Table 1 shows the causes of death for each
group of CIx and Table 2 for each group of the most severely
diseased arterial segment.
3.2. Survival and extent and distribution of atherosclerosis
A four-grade classification of the extent of atherosclerotic
Fig. 1. Causes of death.
(A) In the study cohort, (B) in the Finnish population, age > 65 years. Finnish Centre of
Statistics (Source ISSN ¼ 1799e5051. 2015; http://www.stat.fi/til/ksyyt/ksyyt_2006-
10-26_uut_001.html).
Table 2
Causes of death by arterial segment most affected by atherosclerosis.
Aorto-iliac Femoro-popliteal Crural Total
Malignancy 9 (21%) 29 (18%) 16 (7.7%) 54 (13%)
Endocrine 0 (0%) 4 (2.5%) 25 (12%) 30 (7.4%)
Dementia 1 (2.3%) 4 (2.5%) 13 (6.3%) 18 (4.4%)
Neurological 1 (2.3%) 0 (0%) 1 (0.48%) 2 (0.49%)
Cardiovascular 23 (53%) 90 (56%) 132 (63%) 246 (60%)
Pulmonary 4 (9.3%) 6 (3.8%) 3 (1.4%) 13 (3.2%)
Gastroenterological 2 (4.7%) 9 (5.6%) 4 (1.9%) 15 (3.6%)
Urological 0 (0%) 2 (1.3%) 1 (0.48%) 3 (0.73)
Alcohol 1 (2.3%) 2 (1.3%) 1 (0.48%) 4 (0.97%)
Accident or violent 1 (2.3%) 8 (5.0%) 7 (3.4%) 16 (3.9%)
Not available 0 (0%) 1 (0.63%) 0 (0%) 1 (0.25%)
Miscellaneous 0 (0%) 4 (2.5%) 3 (1.4%) 7 (1.7%)
Death 42 (30%) 159 (38%) 206 (63%) 408 (46%)
Survived 98 (70) 257 (62%) 121 (37%) 479 (64%)
Total 141 417 329 887
Distribution of causes of death varied significantly between arterial segments for
endocrine (p < 0.001), dementia-related (p ¼ 0.035) and cardiovascular (p < 0.001)
causes of death.
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described in theMaterials andmethods section. Crural Index III was
associated with significantly shorter estimated cardiovascular sur-
vival than CIx grades 0, I and II (p < 0.001). Cardiovascular survival
for CIx IVwas significantly shorter compared to all other grades (p<
0.001 for CI 0-II and p ¼ 0.003 for CI III). Kaplan-Meier survival
curves for cardiovascular survival of CIx 0-IV are illustrated in
Fig. 2A. CIx III was associated with significantly shorter estimated
overall survival compared to grades 0, I and II (p < 0.001, p ¼ 0.002
and p < 0.001, respectively) and CI IV was associated with signifi-
cantly shorter estimated overall survival compared to all other
grades (p < 0.001). Kaplan-Meier survival curves for overall survival
for CIx 0-IV are shown in Fig. 2B.
No significant differences in overall survival were found be-
tween different grades of femoro-popliteal or aorto-iliac disease
(data not shown).Table 1
Causes of death for each CIx category.
CIx 0 CIx I CIx
Malignancy 10 (23%) 9 (30%) 17 (
Endocrine 1 (2.3%) 2 (6.7%) 8 (9
Dementia 2 (4.5%) 0 (0%) 3 (3
Neurological 0 (0%) 0 (0%) 0 (0
Cardiovascular 21 (48%) 13 (43%) 44 (
Pulmonary 1 (2.3%) 0 (0%) 6 (7
Gastroenterological 3 (6.8%) 2 (6.7%) 1 (1
Urological 1 (2.3%) 0 (0%) 0 (0
Alcohol 3 (6.8%) 0 (0%) 0 (0
Accident or violent 1 (2.3%) 3 (10%) 1 (1
Not available 0 (0%) 0 (0%) 1 (1
Miscellaneous 1 (2.3%) 1 (3.3%) 1 (1
Death 44 (35%) 30 (43%) 82 (
Survive 82 (65%) 40 (57%) 153
Total 126 70 235
Distribution of causes of death varied significantly among CIx categories for endocrine (p¼Analysis by themost severely diseased arterial segment revealed
that the cohort with severe crural disease had a significantly shorter
cardiovascular (p < 0.001) and overall (p < 0.001) mean estimated
survival compared to the groups with predominantly femoro-
popliteal or aorto-iliac disease (Fig. 3A and B). Both cardiovascular
and overall mean estimated survival was significantly (p ¼ 0.046
and p ¼ 0.015, respectively) shorter in patients with femoro-
popliteal disease than in patients with aorto-iliac disease.
3.3. Baseline factors affecting mortality
According to the significance in univariate analysis, the
following variables were forced into Cox regression analysis for risk
of cardiovascular mortality; age (p < 0.001), CAD (p < 0.001), hy-
pertension (p ¼ 0.063), diabetes (p ¼ 0.001), COPD (p ¼ 0.046),
renal insufficiency (p ¼ 0.105), hyperlipidaemia (p ¼ 0.089),
smoking history (p < 0.001), ABI (p ¼ 0.011) and TBI (p < 0.001).
Correspondingly, variables forced into Cox regression analysis for
overall mortality were age (p ¼ 0.136), CAD (p ¼ 0.002), CVD
(p ¼ 0.183), hypertension (p ¼ 0.110) diabetes (p ¼ 0.001), renal
insufficiency (p < 0.001), hyperlipidaemia (p ¼ 0.019), smoking
history (p < 0.001), ABI (p ¼ 0.003) and TBI (p < 0.001).
3.4. Crural Index and mortality
For cardiovascular mortality, CIx III (Hazard ratio (HR) 2.162,II CIx III CIx IV Total
21%) 14 (9.7%) 4 (3.7%) 54 (13%)
.8%) 6 (4.2%) 13 (12%) 30 (7.4%)
.7%) 2 (1.4%) 11 (10%) 18 (4.4%)
%) 2 (1.4%) 0 (0%) 2 (0.49%)
54%) 95 (66%) 73 (67%) 246 (60%)
.3%) 5 (3.5%) 1 (0.92%) 13 (3.2%)
.2%) 6 (4.2%) 3 (2.8%) 15 (3.6%)
%) 1 (0.69%) 1 (0.92%) 3 (0.73%)
%) 1 (0.69%) 0 (0%) 4 (0.97%)
.2%) 9 (6.3%) 2 (1.8%) 16 (3.9%)
.2%) 0 (0%) 0 (0%) 1 (0.25%)
.2%) 3 (2.1%) 1 (0.92%) 7 (1.7%)
35%) 144 (50%) 109 (65%) 408 (46%)
(65%) 145 (50%) 58 (35%) 479 (64%)
289 167 887
0.035), dementia-related (p < 0.001) and cardiovascular (p < 0.001) causes of death.
Fig. 2. Kaplan-Meier curves show the cumulative survival for a 7-year follow-up.
Curves for Crural Index I-IV and no observable atherosclerosis in crural vessels (CI 0). Left side of the panel: mean estimated survival. (A) Cardiovascular survival and (B) overall
survival.
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3.513, 95% CI 1.93e6.41, p < 0.001) were associated with a signifi-
cant risk in a Cox regression model including high TBI (HR 0.137,
95% CI 0.056e0.333, p < 0.001) as a confounding factor. In addition,
baseline variables including CAD (HR 1.435, 95% CI 1.08e1.91,
p ¼ 0.013), history of smoking (HR 0.597, 95% CI 0.403e0.884,
p ¼ 0.010) and age (HR 0.975, 95% CI 0.962e0.989, p < 0.001) were
also associated with a significantly differing risk of death. Table 3
shows the results of Cox regression analyses. Separate models are
shown for cardiovascular death and overall death with either ABI or
TBI as confounding factors.For overall mortality, CIx IV was significantly associated with
mortality (HR 2.357, 95% CI 1.68e3.83, p < 0.001) in a Cox regres-
sionmodel including TBI (HR 0.208, 95% CI 0.105e0.41, p < 0.001) as
a confounding factor (Table 3).
3.5. Most severely affected arterial segment and mortality
The risk of cardiovascular mortality was significantly increased
when the crural segment was the most severely affected arterial
segment (HR 2.321, 95% CI 1.45e3.73, p < 0.001) in a Cox regression
model including high TBI as a confounding factor (HR 0.092, 95% CI
Fig. 3. Kaplan-Meier curves show the cumulative survival for a 7-year follow.
Curves for the most severely affected vascular segment. Left side of the panel: mean estimated survival. (A) Cardiovascular survival and (B) overall survival.
Table 3
Association between extent of crural vessel atherosclerosis, cardiovascular survival,
overall survival and prognosis.
Model A cardiovascular death TBI Model B cardiovascular death ABI
HR 95% CI p value HR 95% CI p value
CIx IV 3.513 1.93e6.41 <0.001 4.565 2.53e8.24 <0.001
CIx III 2.162 1.23e3.80 0.007 2.402 1.37e4.21 0.002
CIx II 1.618 0.909e2.88 0.102 1.571 0.881e2.80 0.126
CIx I 1.605 0.764e3.37 0.212 1.321 0.630e2.77 0.461
CIx 0 Reference Reference
Model C overall death TBI Model D overall death ABI
HR 95% CI p value HR 95% CI p value
CIx IV 2.537 1.68e3.83 <0.001 3.282 2.19e4.92 <0.001
CIx III 1.395 0.952e2.05 0.088 1.557 1.06e2.29 0.024
CIx II 1.171 0.796e1.72 0.422 1.179 0.798e1.74 0.408
CIx I 1.138 0.676e1.92 0.626 1.019 0.608e1.71 0.944
CIx 0 Reference Reference
CIx 0 and confounding factors for both cardiovascular and overall Cox regression
analyses according to univariate analyses as described in Results. Model A and C TBI
and model B and D ABI.
J.-E. Wickstr€om et al. / Atherosclerosis 264 (2017) 44e50480.039e0.222, p < 0.001). The following baseline variables forced
into the model were associated with a significantly different risk of
death: CAD (HR 1.517, 95% CI 1.14e2.01, p ¼ 0.004), history of
smoking (HR 0.592, 95% CI 0.401e0.873, p ¼ 0.008) and age (HR
0.979, 95% CI 0.966e0.992, p ¼ 0.002).
Crural vessels as themost severely affected arterial segment was
associated with a significantly increased risk of overall mortality
(HR 2.177, 95% CI 1.53e3.10, p < 0.001) in a model with high TBI (HR
0.152, 95% CI 0.078e0.295, p < 0.001) as a confounding factor.
Table 4 shows the results of multivariate analysis.4. Discussion
Classifications of lower extremity PAD using angiographic
analysis have been described [10e13], but these classifications aim
to guide the choice of treatment modality or to classify the severity
of atherosclerosis. CIx was recently shown to associate with sig-
nificant mid-term (up to three years) mortality and amputation at
its higher categories III-IV [17,18]. Observations of the same cohort
Table 4
Association between the most severely affected lower limb arterial segment, cardiovascular survival, overall survival and prognosis.
Model A cardiovascular death TBI Model B cardiovascular death ABI
HR 95% CI p value HR 95% CI p value
Crural 2.321 1.45e3.73 <0.001 2.578 1.61e4.11 <0.001
Femoro-popliteal 1.003 0.635e1.58 0.990 1.030 0.657e1.61 0.898
Aorto-iliac Reference Reference
Model C overall death TBI Model D overall death ABI
HR 95% CI p value HR 95% CI p value
Crural 2.177 1.53e3.10 <0.001 2.473 1.74e3.52 <0.001
Femoro-popliteal 0.944 0.657e1.32 0.737 1.000 0.716e1.40 0.999
Aorto-iliac Reference Reference
Reference aorto-iliac segment and confounding factors for both cardiovascular and overall Cox regression analyses according to univariate analyses as described in Results.
Model A and C: TBI; model B and D: ABI.
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tions, showing that both cardiovascular and over-all mortality at
CIx categories III and IV increase even further during long-term
follow-up, compared to lower categories.
Significant atherosclerotic lesions at aorto-iliac or femoro-
popliteal segments are associated with mortality [15]. Hemody-
namically significant aorto-iliac lesions in particular have been
shown to be associated with an increased risk of major adverse
cardiovascular and cerebrovascular events (MACCE) [15,16,20].
Crural atherosclerosis has, controversially, been reported to both
have no effect on survival [16] and to predict poor survival [20,21].
PAD patients with isolated crural disease have previously been
shown to have poorer life expectancy compared to patients with
multilevel disease, even if the multilevel disease involves the crural
arteries [20]. In addition, an extensive study, utilising non-invasive
screening of atherosclerosis at three segments of lower limb
vascular beds, demonstrated that distal atherosclerosis is prog-
nostic for poor survival [21]. There is still some controversy about
the consequences of disease localisation and patient outcome in the
literature. However, no earlier studies showing a correlation be-
tween the level of lower limb atherosclerosis and survival have
focused on the possible value of the extent of atherosclerosis in
lower extremity arteries. Our observations further support the idea
that extensive atherosclerosis in crural arteries is associated with
remarkably poor patient outcome, additionally highlighting the
pronounced proportion of cardiovascular deaths among patients
with CIx III-IV (66%). This emphasises the impact of a heavy burden
of generalised atherosclerosis and cardiovascular disease in pa-
tients with a high CIx, as well as the importance of implementing
the best available medical treatment for all PAD patients.
Clinical determination of causes of death and possible inaccur-
acies of death certificates are potential sources of significant error
for a study such as this one. Although Finland has the highest au-
topsy rates of the Nordic countries (http://www.stat.fi/til/ksyyt/
2013/ksyyt_2013_2014-12-30_laa_001_en.html), known PAD may
in particular exaggerate the proportion of cardiovascular causes of
death, in death certificates within the study population, which
might render comparisons to the general population inaccurate.
Within the study population of symptomatic PAD patients, how-
ever, this bias is likely to affect all patient groups in a similar
manner, with a substantial 24% difference in cardiovascular mor-
tality between patients with CIx I and CIx IV adding weight to the
significance of this finding.
The clinical significance of crural vessel atherosclerosis is not
limited to poor life expectancy alone. Isolated tibial disease is also
associated with worse outcomes after revascularisation, evenwhen
compared to multilevel disease [22]. Our earlier [17,18] and present
observations of CIx, together with an interesting investigation
demonstrating that poor runoff is predictive of poor patientsurvival [14], uphold that the extent of crural atherosclerosis is
predictive for both revascularisation outcome and patient survival.
Whether the newly applied classification (WIfI) for severity of
ischaemic ulcers will be predictive pf patient survival remains an
interesting target for future research, as does the association ofWIfI
with runoff or CIx [23,24].
Aorto-iliac calcification and atherosclerotic lesions have been
shown to be associated with poor patient outcome, defined as
MACCE or death [16]. Our results demonstrate a 30% mortality
among patients with the aorto-iliac segment most severely
affected, but a 63% mortality among patients with severe crural
segment disease. The severity and extent of atherosclerosis at the
aorto-iliac segment in the present study are based on the TASC II
classification and not on a simple yes/no evaluation of atheroscle-
rosis at any given segment. This might explain different results
between the present study and earlier observations. In previous
studies, outcome was measured by MACCE as well as survival [16],
not cardiovascular and overall mortality. According to our results,
extensive atherosclerosis of crural arteries is associated with the
worst patient outcome.
Aetiological differences between large and small vessel PAD
have previously been characterised, with current smoking and
dyslipidaemia in particular being associated with large vessel dis-
ease and diabetes with small vessel disease [25]. This can be
considered to be in line with the findings in our study, where a
positive smoking history was rare in patients with predominantly
crural disease (9%) compared to those with aorto-iliac or femoro-
popliteal disease (52 and 32%, respectively) [18]. Diabetes was
similarly relatively rare (23%) in patients with predominantly
aorto-iliac disease, as compared to those with femoro-popliteal or
crural disease (41 and 53%, respectively). In fact, in the present
cohort, smoking was associated with decreased cardiovascular
mortality. This might be due to early smoking related deaths, such
as those caused by malignancies, among smokers [26], and typical
onset of symptomatic PAD at an older age [27] [18].
Co-morbidities in the present study are similar to those found in
earlier studies on PAD [4,28e30]. End-stage renal disease and
diabetes are associated with crural PAD [31e34]. Furthermore,
these risk factors, together with critical ischemia, are shown to be
associated with a poor prognosis [20]. Based on our observations,
mortality correlates with the extent of atherosclerosis in crural
vessels. The three most common causes of death during follow-up
in the study cohort were cardiovascular (60%), malignancy (13.2%)
and endocrine (7.3%). All baseline variables considered, extensive
crural atherosclerosis measured as CIx is the strongest independent
predictor of cardiovascular and overall mortality.
The aim of this study was to verify the association of the Crural
Index with both cardiovascular and overall mortality during a long
follow-up of up to 7 years. CIx is feasible in everyday vascular
J.-E. Wickstr€om et al. / Atherosclerosis 264 (2017) 44e5050practice and is a good indicator of patient outcome. It is applicable
to assess patient mid-term [17,18] and long-term survival among
patients with PAD. CIx may be valuable when making decisions on
extensive, high-risk revascularisations for patients with multiple
comorbidities.
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